Recursion Pharmaceuticals Inc - Ordinary Shares - Class A
RXRX
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.29B
Close$
Share Statistics
| Market cap | $2.29 Billion |
|---|---|
| Enterprise Value | $1.83 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-1.44 |
| Beta | 1.03 |
| Outstanding Shares | 532,460,085 |
Return
| Return on Equity | -56.71% |
|---|---|
| Return on Assets | -42.79% |
| Return on Invested Capital | -51.17% |
Valuation & Multiples
| P/E Ratio | -4.19 |
|---|---|
| PEG | 17.62 |
| Price to Sales | - |
| Price to Book Ratio | 3.47 |
| Enterprise Value to Revenue | 33.39 |
| Enterprise Value to EBIT | -3.28 |
| Enterprise Value to Net Income | -4 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 5, 2026
EPS Estimate
$-0.24
Average shareholder expectationRevenue Estimate
$10.97 M
Average shareholder expectationNext Earnings Call
Expected Date
November 4, 2026
EPS Estimate
$-0.22
Average shareholder expectationRevenue Estimate
$12.98 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 53.25% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.07%▼ 68.69% |
|---|---|
| Total Invested | $1.44M▼ 99.89% |
| Investors Holding | 10▼ 351.00% |
ESG Score
No data
About Recursion Pharmaceuticals Inc
218 employeesRecursion is a clinical-stage biotechnology company decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patient...